{
  "query": "Can immunotherapy be combined with chemotherapy?",
  "response": "Yes, combination therapy is increasingly standard. KEYNOTE-189 showed pembrolizumab + chemotherapy improved overall survival vs chemotherapy alone in metastatic NSCLC. The combination appears to have synergistic effects.",
  "attention": {
    "sources": [
      "KEYNOTE-189.pdf",
      "combination-therapy-review.pdf"
    ],
    "weights": [
      0.65,
      0.35
    ],
    "patterns": [
      "sources:2",
      "high-confidence",
      "outcome:success"
    ]
  },
  "outcome": "success",
  "confidence": 0.93,
  "timestamp": 1760058208796,
  "memory_type": "long-term",
  "id": "4387f70c77887cf71616cded4e530d14126da2b7ee3127dd882f4815cd114b3d"
}